Skip to content
HealthMinute.TV

HealthMinute.TV

  • Home
  • Derm.City
  • Derm.Business
  • Chronicle Companies
  • Contact
April 6, 2022 chroniclepublishing Technology

New study shows 1,064 nm lasers most effective for tattoo removal

A pre-clinical comparative study has shown that 1,064 nm lasers may be most effective in tattoo removal.

March 30, 2022 chroniclepublishing atopic dermatitis

Difamilast ointment shows efficacy in treating atopic dermatitis

A new study found difamilast ointment 1% to be safe and efficacious in the treatment of atopic dermatitis (AD).

March 23, 2022 chroniclepublishing psoriasis

Psoriasis patients with and without psoriatic arthritis self-report higher analgesic use

According to a new study, psoriasis patients, with and without psoriatic arthritis (PsA), self-report using analgesics more than those without the disease. This may be due to increased joint pain.

March 16, 2022 chroniclepublishing psoriasis

Ustekinumab less effective for psoriasis in lower extremities, according to study

A new study has shown that clinical response in psoriasis patients treated with ustekinumab tends to vary by anatomical region, with the lower extremities seeing the least response.

March 10, 2022 chroniclepublishing atopic dermatitis

Dupilumab-induced ocular surface disease more frequently associated with AD, study shows

According to a new study, dupilumab-induced ocular surface disease (DIOSD) appears to occur more frequently in patients with atopic dermatitis (AD) than in patients with other conditions being treated with the biologic.

March 3, 2022 chroniclepublishing Dermatology, research

University of Toronto establishes Chair in Ethnodermatology position

The University of Toronto has just established the AbbVie Chair in Ethnodermatology, one of the first positions of its kind, to support diversity in dermatology training, research and care, according to a press release.

February 23, 2022 chroniclepublishing psoriasis

Study shows early response to biologics linked to stable long-term efficacy in psoriasis

Findings from a new study has shown that early response to ixekizumab and ustekinumab is associated with maintaining stable long-term skin clearance in patients with moderate-to-severe psoriasis.

February 16, 2022 chroniclepublishing psoriasis

Self-help interventions help reduce shame and improve QOL in psoriasis patients, study shows

According to a new study, some psoriasis patients may experience a reduction in shame and improvement in quality of life (QOL) after exposure to self-help interventions.

February 9, 2022 chroniclepublishing Dermatology

Researchers review HS biomarkers and criteria for validation in clinical trials

Researchers have reviewed the literature on biomarkers for hidradenitis suppurativa (HS) to evaluate the validity of these biomarkers and to identify the reasons for their lack of use in clinical trials.

February 2, 2022 chroniclepublishing psoriasis

Psoriasis patients experience vaccine hesitancy and treatment disruptions during pandemic

A new study evaluates vaccine hesitancy and medication changes in psoriasis patients during the Covid-19 pandemic.

Posts navigation

Older posts
Newer posts
Create a website or blog at WordPress.com
HealthMinute.TV
Create a website or blog at WordPress.com
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Subscribe Subscribed
    HealthMinute.TV
    Join 63 other subscribers

    Have a WordPress.com account? Log in now.

  • HealthMinute.TV
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar
Loading Comments...
Design a site like this with WordPress.com
Get started